Clinical Trials Logo

Tumors That Express CA 19-9 clinical trials

View clinical trials related to Tumors That Express CA 19-9.

Filter by:
  • None
  • Page 1

NCT ID: NCT03118349 Terminated - Clinical trials for Pancreatic Carcinoma

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Start date: June 1, 2017
Phase: Phase 1
Study type: Interventional

Open label, nonrandomized, dose-escalation with cohort expansion study of MVT-5873/MVT-1075 in subjects with previously treated, Carbohydrate Antigen 19-9 (CA19-9) positive malignancies (e.g., pancreatic adenocarcinoma).